Activity Preview

Live

Clinical EP Learning Pathway - Heart Rhythm 2017

Activity Type:

  • Course

Release Date: 1/1/2018

Expiration Date: 12/31/2018

  • CME: 5.5
  • Participation - no CE credit: 5.5

Description

The Clinical EP Learning Pathway is a collection of presentations from Heart Rhythm 2017 held May 10 - 13 in Chicago, IL.   This  pathway explores the role of anatomic variations for left atrial appendage closure and health economics of this procedure, the optimal management of patients with heart failure and atrial fibrillation, ECG clues to help with arrhythmia diagnosis and the management of arrhythmias in heart failure and uncommon cardiomyopathies.

Earn up to 5.5 CME credits and 5.5 MOC points*

(*Each presentation is up to 0.5 CME credits/MOC points)

List Price

$125

Member

Complimentary

Non-Member

$125

Clinical EP Learning Pathway include the following presentations from Heart Rhythm 2017:

From P Wave Morphology to the Site of Origin and Mechanism of SVT
Faculty - Teiichi Yamane, MD, PhD, FHRS

12 Lead (Holter) ECG in “Polymorphic” VPC: Sort Out the Chaos Before You Treat It
Faculty - Helmut Puererfellner, MD

How LAA Anatomical Variants Influence Procedure Success and Closure Device Selection
Faculty - Vivek Y. Reddy, MD

Is LAA Closure a Cost Effective Alternative to Oral Anticoagulation?
Faculty - Mintu P. Turakhia, MD, MS

Atrial Fibrillation and Heart Failure: A Review of Studies Prior to 2016
Faculty - Albert L. Waldo, MD, FHRS, CCDS

Is There Still a Role for Anti-Arrhythmic Therapy in AF Patients with Heart Failure?
Faculty – Isabelle C. Van Gelder, MD, PhD

Stress Cardiomyopathy
Faculty - Ilan S. Wittstein, MD

Acute Myocarditis
Faculty - Jeffrey A. Towbin, MD

Infiltrative Cardiomyopathies
Faculty - Christopher J. McLeod, MD, PhD, FHRS

Managing Ventricular Arrhythmias in End Stage Heart Failure: Pharmacologic Considerations
Faculty - Ratika Parkash, MD, MS, FHRS

Managing Ventricular Arrhythmias in Patients with End Stage Heart Failure: The Role of Catheter Ablation
Faculty - Frederic Sacher, MD, PhD

 

 

Learning Objectives

Upon completion of this educational activity, participants will be able to:

1. Assess the role of anatomic variations in LAA Closure and the impact of this procedure on health economics.
2. Impact and management of atrial fibrillation in patients with heart failure.
3. Use ECG clues to decipher arrhythmia origin and mechanism
4. Management of ventricular arrhythmias in end stage heart failure
5. Identify strategies for arrhythmia management in cardiomyopathies including infiltrative,Takotsubo cardiomyopathies and acute myocarditis

Access Activity

Target Audience

Clinical Cardiac EPs
Directors of EP Labs
Cardiologists
EP Fellows

Faculty & Disclosures

Faculty - 

Teiichi Yamane, MD, PhD, FHRS
Disclosure - None

Helmut Puererfellner, MD
Disclosure - Medtronic Bakken Research Center, St. Jude Medical, Biosense Webster, Inc., Boehringer Ingelheim, Bayer HealthCare, LLC, Boston Scientific Corp., Pfizer, Inc., Daiichi.

Vivek Y. Reddy, MD
Disclosure – Medtronic, Inc., Biotronik, CardioFocus, Inc., Impulse Dynamics USA, EBR Systems, Boston Scientific Corp., Biosense Webster, Inc., Abbott Vascular, Iowa Approach Incorporated, VytronUS, Inc., Acutus Medical Inc, Luxcath, DC Devices Incorporated, EpiEP, Magnetecs, VytronUS, Inc., Iowa Approach Incorporated, BackBeat, BioSig Technologies, St. Jude Medical, CardioFocus, Inc..

Mintu P. Turakhia, MD, MS
Disclosure – Daiichi, Medtronic, Inc., St. Jude Medical, Cyberheart, Metrica Health, Janssen Pharmaceuticals, Veterans Administration.

Albert L. Waldo, MD, FHRS, CCDS
Disclosure – Abbott Vascular, Biotronik, Daiichi, Biosense Webster, Inc., Gilead Sciences, Inc., CardioInsight Technologies, AtriCure, Inc., ChanRx, Pfizer, Inc., Bard Electrophysiology, St. Jude Medical, Janssen Pharmaceuticals, Bristol Meyers Squibb, Pfizer, Inc.

Isabelle C. Van Gelder, MD, PhD
Disclosure – Medtronic, Inc.

Ilan S. Wittstein, MD
Disclosure – None

Jeffrey A. Towbin, MD
Disclosure – National Institutes for Health

Christopher J. McLeod, MD, PhD, FHRS
Disclosure – None

Ratika Parkash, MD, MS, FHRS
Disclosure – Boehringer Ingelheim, Medtronic, Inc., Sanofi Aventis, St. Jude Medical, Bayer HealthCare, LLC.

Frederic Sacher, MD, PhD
Disclosure – Sorin Group, St. Jude Medical, Biosense Webster, Inc., Medtronic, Inc., Boehringer Ingelheim, Bayer HealthCare, LLC, Bristol Meyers Squibb, Boston Scientific Corp.

Planners –
Thomas Deering, MD, FHRS
HR2017 Program Chair
Disclosure - Pfizer, Inc., Medtronic, Inc., Zywie, CorMatrix, Boston Scientific Corp., Janssen Pharmaceuticals, Spectranetics Corporation, St. Jude Medical, Sorin Group.

Andrea Russo, MD, FHRS
HR2017 Abstract Chair
Disclosure – Medtronic, Inc., Boston Scientific Corp., St. Jude Medical, Biotronik. Boehringer Ingelheim

Staff –
Russell Werlinich, CMP
Disclosures – None

Chloe Thomas
Disclosures - None

 

CME Information

ACCREDITATION STATEMENT
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT
The Heart Rhythm Society designates this enduring material for a maximum of 5.5 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

ABIM MAINTENANCE OF CERTIFICATION (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

CME-MOC_badge.jpg

Disclosures

DISCLOSURE OF FACULTY’S COMMERCIAL RELATIONSHIP(S)

It is the policy of the Heart Rhythm Society to ensure balance, independent objectivity, and scientific rigor in all its certified educational activities. Everyone involved in the planning and participation of continuing medical education activities is required to disclose any real or apparent conflicts of interest related to the content in his/her presentation(s) and also disclose discussions of unlabeled/unapproved uses of drugs or devices during his/her presentation(s).

Faculty - 

Teiichi Yamane, MD, PhD, FHRS
Disclosure - None

Helmut Puererfellner, MD
Disclosure - Medtronic Bakken Research Center, St. Jude Medical, Biosense Webster, Inc., Boehringer Ingelheim, Bayer HealthCare, LLC, Boston Scientific Corp., Pfizer, Inc., Daiichi.

Vivek Y. Reddy, MD
Disclosure – Medtronic, Inc., Biotronik, CardioFocus, Inc., Impulse Dynamics USA, EBR Systems, Boston Scientific Corp., Biosense Webster, Inc., Abbott Vascular, Iowa Approach Incorporated, VytronUS, Inc., Acutus Medical Inc, Luxcath, DC Devices Incorporated, EpiEP, Magnetecs, VytronUS, Inc., Iowa Approach Incorporated, BackBeat, BioSig Technologies, St. Jude Medical, CardioFocus, Inc..

Mintu P. Turakhia, MD, MS
Disclosure – Daiichi, Medtronic, Inc., St. Jude Medical, Cyberheart, Metrica Health, Janssen Pharmaceuticals, Veterans Administration.

Albert L. Waldo, MD, FHRS, CCDS
Disclosure – Abbott Vascular, Biotronik, Daiichi, Biosense Webster, Inc., Gilead Sciences, Inc., CardioInsight Technologies, AtriCure, Inc., ChanRx, Pfizer, Inc., Bard Electrophysiology, St. Jude Medical, Janssen Pharmaceuticals, Bristol Meyers Squibb, Pfizer, Inc.

Isabelle C. Van Gelder, MD, PhD
Disclosure – Medtronic, Inc.

Ilan S. Wittstein, MD
Disclosure – None

Jeffrey A. Towbin, MD
Disclosure – National Institutes for Health

Christopher J. McLeod, MD, PhD, FHRS
Disclosure – None

Ratika Parkash, MD, MS, FHRS
Disclosure – Boehringer Ingelheim, Medtronic, Inc., Sanofi Aventis, St. Jude Medical, Bayer HealthCare, LLC.

Frederic Sacher, MD, PhD
Disclosure – Sorin Group, St. Jude Medical, Biosense Webster, Inc., Medtronic, Inc., Boehringer Ingelheim, Bayer HealthCare, LLC, Bristol Meyers Squibb, Boston Scientific Corp.

Planners – 
Thomas Deering, MD, FHRS
HR2017 Program Chair
Disclosure - Pfizer, Inc., Medtronic, Inc., Zywie, CorMatrix, Boston Scientific Corp., Janssen Pharmaceuticals, Spectranetics Corporation, St. Jude Medical, Sorin Group.

Andrea Russo, MD, FHRS
HR2017 Abstract Chair
Disclosure – Medtronic, Inc., Boston Scientific Corp., St. Jude Medical, Biotronik. Boehringer Ingelheim

Staff – 
Russell Werlinich, CMP
Disclosures – None

Chloe Thomas
Disclosures - None

REPORTING CONFLICT OF INTEREST OR BIAS IN A PRESENTATION

Allegations of conflict of interest and bias are taken seriously and are investigated by the Ethics Oversight Committee, Scientific Sessions Program Committee and/or the Education Committee. Your complaint will be referred to the appropriate committee, and you will be informed in writing of the outcome of its review and decision. Submit a confidential complaint by completing the form at http://www.hrsonline.org/About-HRS/Heart-Rhythm-Society-Governance/Conflict-of-Interest-Complaint-Form#axzz32C70AtsV or submit an email message to scientific.sessions@HRSonline.org.

Access Activity